Oxford Immunotec Global PLC·4

Mar 13, 4:32 PM ET

RANDALL PATRICIA 4

4 · Oxford Immunotec Global PLC · Filed Mar 13, 2020

Insider Transaction Report

Form 4
Period: 2020-03-12
RANDALL PATRICIA
VP and General Counsel
Transactions
  • Exercise/Conversion

    SHARE OPTION(RIGHT TO BUY)

    2020-03-1215,0740 total
    Exercise: $0.09Exp: 2020-03-31Ordinary Shares (15,074 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2020-03-12$0.09/sh+15,074$1,35723,724 total
Footnotes (1)
  • [F1]Became fully exercisable on April 1, 2014.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4